Renal damage in obstructive nephropathy is decreased in Skp2-deficient mice

American Journal of Pathology

Volumn 171, Issue 2, 2007, Pages 473-483

  Suzuki, Sayuri ^a   Fukasawa, Hirotaka ^a   Kitagawa, Kyoko ^a   Uchida, Chiharu ^a   Hattori, Takayuki ^a   Isobe, Tomoyasu ^a   Oda, Toshiaki ^a   Misaki, Taro ^a   Ohashi, Naro ^a   Nakayama, Keiko ^b   Nakayama, Keiichi I ^c   Hishida, Akira ^a   Yamamoto, Tatsuo ^a   Kitagawa, Masatoshi ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; MESSENGER RNA; PROTEIN P27; S PHASE KINASE ASSOCIATED PROTEIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FIBROSING ALVEOLITIS; KIDNEY DISEASE; KIDNEY INJURY; KIDNEY TUBULE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; URETER OBSTRUCTION; WESTERN BLOTTING;

EID: 34548363730     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.070279     Document Type: Article

References (30)

1. Walton G, Buttyan R, Garcia ME, Olsson CA, Hensle TW, Sawczuk IS: Renal growth factor expression during the early phase of experimental hydronephrosis. J Urol 1992, 148:510-514
2. Klahr S, Morrissey J: Obstructive nephropathy and renal fibrosis. Am J Physiol 2002, 283:F861-F875
3. Couser WG, Johnson RJ: Mechanisms of progressive renal disease in glomerulonephritis. Am J Kidney Dis 1994, 23:193-198
4. Gobe GC, Axelsen RA: Genesis of renal tubular atrophy in experimental hydronephrosis in the rat: role of apoptosis. Lab Invest 1987, 56:273-281
5. Morgan DO: Principles of CDK regulation. Nature 1995, 374:131-134
6. 1 cyclin-dependent kinases. Genes Dev 1995, 9:1149-1163
7. kip1 cyclin-dependent kinases inhibitor prevented by rapamycin. Nature 1994, 372:570-573
8. kip1, a cyclin-dependent kinases inhibitor and potential mediator of extracellular antimitogenic signals. Cell 1994, 78:59-66
9. kip1 for restriction point control of the fibroblast cell cycle. Science 1996, 272:877-880
10. kip1. Kidney Int 1997, 51:1088-1099
11. Kamb A: Cell-cycle regulators and cancer. Trends Genet 1995, 11:136-140
12. Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 1995, 81:323-330
13. Weissman AM: Regulating protein degradation by ubiquitination. Immunol Today 1997, 18:189-198
14. Hershko A, Ciechanover A: The ubiquitin system. Annu Rev Biochem 1998, 67:425-479
15. Carrano AC, Eytan E, Hershko A, Pagano M: SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1999, 1:193-199
16. Tsvetkov LM, Yeh KH, Lee SJ, Sun H, Zhang H: p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr Biol 1999, 9:661-664
17. kip1, polyploidy and centrosome overduplication. EMBO J 2000, 19:2069-2081
18. Morrissey JJ, Ishidoya S, McCrachen R, Klahr S: Control of p53 and p21 (WAF1) expression during unilateral ureteral obstruction. Kidney Int 1996, 50(Suppl 57):S84-S92
19. KIP1 after unilateral ureteral obstruction is independent of angiotensin II. Kidney Int 2002, 61:68-79
20. Schaefer L, Macakova K, Raslik I, Micegova M, Gröne HJ, Schönerr E, Robenek H, Echtermeyer FG, Grässel S, Bruckner P, Schaefer RM, Iozzo RV, Kresse H: Absence of decorin adversely influences tubulointerstitial fibrosis of the obstructed kidney by enhanced apoptosis and increased inflammatory reaction. Am J Pathol 2002, 160:1181-1191
21. kip1 safeguards against inflammatory injury. Nat Med 1998, 4:575-58
22. CIP1/WAF1 limits interstitial cell proliferation following ureteric obstruction. Am J Physiol 1999, 277:F948-F956
23. Sheehan DC, Hrapchak B: Theory and Practice of Histotechnology. Columbus, Battelle Press, 1980, pp 188-194
24. Kip1 degradation and induces S phase in quiescent cells. Nature Cell Biol 1999, 1:207-214
25. Gstaiger M, Jordan R, Lim M, Catzavelos C, Mestan J, Slingerland J, Krek W: Skp2 is oncogenic and overexpressed in human cancers. Proc Natl Acad Sci USA 2001, 98:5043-5048
26. Cip1 in S phase. J Biol Chem 2003, 278:25752-25757
27. Zeisberg M, Kalluri R: The role epithelial-to mesenchymal transition in renal fibrosis. J Mol Med 2004, 82:175-181
28. Hay ED, Zuk A: Transformations between epithelium and mesenchyme: normal, pathological, and experimentally induced. Am J Kidney Dis 1995, 26:678-690
29. Kalluri R, Neilson EG: Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003, 112:1776-1784
30. Tashiro K, Tamada S, Kuwabara N, Komiya T, Takekida K, Asai T, Iwao H, Sugimura K, Matsumura Y, Takaoka M, Nakatani T, Miura K: Attenuation of renal fibrosis by proteasome inhibition in rat obstructive nephropathy: possible role of nuclear factor kappaB. Int J Mol Med 2003, 12:587-592